Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Design returned 242 record(s)
|
|
Sunday, 07/30/2017
|
Teaching a Large, Project-Based Statistical Consulting Class
Emily Griffith, NC State University
|
Rerandomization: a Flexible Framework for Experimental Design
Kari Lock Morgan, Penn State University
|
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Richard C. Zink, JMP Life Sciences, SAS Institute, Inc.
2:05 PM
|
Data Editing: How Much Is Too Much?
Rebecca Ahrnsbrak, Substance Abuse and Mental Health Services Administration; Chrishelle Lawrence, U.S. Energy Information Administration; Darcy Miller, National Agricultural Statistics Service; Kirk Mueller, U.S. Bureau of Labor Statistics; Justin Nguyen, U.S. Census Bureau
2:05 PM
|
Design, Implementation, and Impact of Different Approaches to Professional Development for Teachers of Statistics
Hollylynne Lee, NC State University; Katherine T. Halvorsen, Smith College; Victoria Weber, Meredith College; Asli Mutlu, North Carolina State University; Michael A. Posner, Villanova University
2:05 PM
|
Redesigning the National Health Interview Survey Questionnaire
Stephen Blumberg, National Center for Health Statistics
2:05 PM
|
Randomziation and Permutation Tests of Network Structure
Mark M. Fredrickson, University of Illinois at Urbana-Champaign
2:05 PM
|
Sequential Test Planning for Polymer Composites
I-Chen Lee; Yili Hong, Virginia Tech; Sheng-T Tseng, National Tsing-Hua University; Tirthankar Dasgupta, Rutgers University
2:05 PM
|
Techniques for Matched Randomization in Sequential Enrollment Trials
Jonathan J Chipman, Vanderbilt University; Cole Beck, Vanderbilt University; Robert A Greevy, Jr, Vanderbilt University
2:05 PM
|
An Optimized Adaptive Enrichment Design for Multi-Arm Trials
Michael Rosenblum, Johns Hopkins University; Aaron Fisher, Johns Hopkins University; Jon Steingrimsson, Johns Hopkins University; Joshua A Betz, Johns Hopkins University
2:25 PM
|
Expanding the Survey of Doctorate Recipients
Wan-Ying Chang, NSF/NCSES; Daniel Foley, NSF/NCSES; Karen Grigorian, NORC; Michael Yang, NORC; Lance Selfa, NORC
2:25 PM
|
Spatio-Temporal Balanced Sampling Design for Longitudinal Natural Resources Survey
Zhengyuan Zhu, Iowa State University
2:30 PM
|
Bayesian Interval Based Dose Finding Designs and a Web-Based Statistical Tool
Yuan Ji, NorthShore University HealthSystem/University of Chicago; Sue-Jane Wang, FDA; Shengjie Yang, NorthShore University HealthSystem
2:45 PM
|
Redirected Inbound Call Sampling - an Example of Fit for Purpose Non-Probability Sample Design
Burton Levine, RTI International; Karol Krotki, RTI; Georgiy Bobashev, RTI International
2:45 PM
|
Re-Envisioning and Re-Building the Survey of Income and Program Participation
Jason Fields, U.S. Census Bureau
2:45 PM
|
Improving the External Validity of Nonprobability Samples
Mansour Fahimi, GfK
3:05 PM
|
Model-Assisted Estimation of Proportions in Repeated Survey with Complex Rotation Pattern: Application to the Current Population Survey
Daniel Bonnéry, University of Maryland
3:20 PM
|
Assessing Product Downsizing, Upsizing, and Product Churn in the Consumer Price Index Using Nielsen Scanner Data
Jenny FitzGerald, U.S. Bureau of Labor Statistics
3:35 PM
|
More Information Is Better! Where Do We Get it and How Do We Use It?
Stephanie Michelle Coffey, U.S. Census Bureau; JPSM University of Maryland
4:05 PM
|
Multi-Regional Clinical Trials and the ICH E17 Draft Guidance
Bruce Binkowitz, Shionogi, Inc.; Aloka Chakravarty, US FDA, CDER; Steve Snapinn, Amgen; Romi Singh, Pfizer
4:05 PM
|
A Maximum Likelihood Approach to Power Calculations for Stepped Wedge Designs of Binary Outcomes
Xiaomei Liao, AbbVie; Lauren Kunz, NIH; Sharon-Lise Normand, Harvard Medical School; Donna Spiegelman, Harvard T.H. Chan School of Public Health
4:05 PM
|
Investigation on Combining Phase II Proof-Of-Concept Trial with Dose Finding Trial
Yutao Liu, Columbia University; Qiqi Deng, Boehringer Ingelheim Pharmaceuticals, Inc.; Ken Cheung, Deptment of Biostatistics, Columbia University
4:05 PM
|
Modeling Nonresponse Bias Likelihood and Response Propensity: The Design and Implementation of Statistical Models to Identify Cases for Interventions During Data Collection
Daniel Pratt, RTI International; Jeffrey Rosen, RTI International; Michael Duprey, RTI International; Jamie Wescott, RTI International
4:20 PM
|
A Statistical Framework for Downscaling Climate Model Information to Enhance Infrastructure Design
Ernst Linder, Department of Mathematics and Statistics, University of New Hampshire; Meng Zhao, University of New Hampshire; Yiming Liu, University of New Hampshire
4:20 PM
|
Adaptive Design and Statistical Consideration in Clinical Trials
Steven Sun; Grace Liu, Johnson & Johnson; Tianmeng Lyu, Univ. Minnesota Biostatistics Dept.
4:25 PM
|
Analyzing the Need for an Oversample of Low Income Beneficiaries in the Medicare Current Beneficiary Survey
Ying Li, NORC at the University of Chicago; Whitney Murphy, NORC at the University of Chicago; Kirk Wolter, NORC at the University of Chicago; Debra Reed-Gillette , Centers for Medicare & Medicaid Services; Cheryl L. Sharpless, CMS
4:35 PM
|
Robust Parameter Design Using Computer Experiments
V. Roshan Joseph, Georgia Institute of Technology; Li Gu, Wells Fargo & Company; Shan Ba, Procter & Gamble Company; William Myers, The Procter & Gamble Company
4:45 PM
|
Basket Trial Considerations in Phase Ib/IIa Oncology Studies of Targeted Therapy
Yihua Zhao, Boehringer Ingelheim Pharmaceuticals, Inc.
4:45 PM
|
Optimization of Adaptive Survey Design from a Bayesian Perspective. Two Case Studies
Barry Schouten, Statistics Netherlands; Joep Burger, Statistics Netherlands; Nino Mushkudiani, Statistics Netheriands
4:50 PM
|
Software Solutions to Sample Design Problems That Are Equivalent to Solving a Transshipment Problem
Richard Sigman, Westat; Mike Kwanisai, Westat
4:50 PM
|
Bounded-Width Confidence Interval for Gini Index Under Complex Survey
Francis Bilson Darku, University of Texas at Dallas; Bhargab Chattopadhyay, Indian Institute of Information Technology - Vadodara
4:50 PM
|
A Cautionary Note on the Validation Method for Molecular Classification Studies
Li-Xuan Qin, Memorial Sloan Kettering Cancer Center
4:55 PM
|
Semi-Analytical Approach for Designing Accelerated Degradation Tests
Sheng-T Tseng, National Tsing-Hua University; I-Chen Lee; Yili Hong, Virginia Tech
4:55 PM
|
Using Bayesian Methods to Rank Cases Based on Response Propensity During Data Collection
James Wagner, University of Michigan
5:05 PM
|
Statistical Modeling on Ingredients for Sugar Reduction
Shankang Qu, PepsiCo; Patricia Delease, PepsiCo
5:05 PM
|
Evaluation of Adaptive Sample Size Re-estimation (SSR) Designs:start small then ask for more?
Chaofeng Liu
5:05 PM
|
Test of Adaptive Survey Design from a Bayesian Perspective in a Longitudinal Survey
Peter Lundquist, Statistics Sweden; Anton Johansson, Statistics Sweden; Gabriele Durrant, University of Southampton
5:20 PM
|
Optimal Design of Accelerated Degradation Tests for Wiener Degradation Processes with Budget Constraint and Time-Censoring
Jen Tang, Purdue University; Ming-Yung Lee, Providence University
5:20 PM
|
Design and Implementation of a Rapid, Population-Based Survey for the Zika Emergency Response Effort in Puerto Rico
Holly Shulman, CDC; Brian Morrow, CDC; Beatriz Salvesen von Essen Lopez, Puerto Rico Department of Health; Wanda Hernandez Virella, Puerto Rico Department of Health
5:20 PM
|
Integrating the Evidence from Evidence Factors in Observational Studies
Bikram Karmakar, University of Pennsylvania; Benjamin French, Radiation Effects Research Foundation; Dylan Small, University of Pennsylvania
5:20 PM
|
Design of Dose Finding Studies Under MCP-Mod
Jose Pinheiro, Johnson & Johnson
5:25 PM
|
|
Monday, 07/31/2017
|
The Connectivity of Data Science to Survey Design and Statistical Practice
Steven Cohen, RTI International
|
How We Take Advantage of Big Data When Dealing with the Dilemma in Early-Phase Oncology?
Shaoyi Li, Celgene
|
Design of Experiment for Big Data Era
Dennis K.J. Lin, Penn State University
|
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Sungjin Kim, Cedars-Sinai Medical Center; Marcio Diniz, Cedars Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center
|
A Curtailed Design for Selecting the t Best Among Bernoulli Treatments and a Control
Mingyue Wang, Syracuse University; Pinyuen Chen, Syracuse University
|
Two-Stage Design for Phase II Cancer Clinical Trials with Multiple Endpoints
Hui Gu, Rutgers University; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health; Yaqun Wang, Rutgers; Kejian Liu, Celgene
|
Interim Analysis with Short-Term and Long-Term Endpoint in Adaptive Group Sequential Design
Lin Pan, ICON PLC; Jill Stankowski, ICON PLC
|
Sequential Clinical Trial Design for Basket Phase II
Shilan Li; Hongbin Fang, Georgetown University; Ming T Tan, Georgetown University
|
What Is the Best Design for Dose-Finding Trials with Small Number of Doses?
Lai Wei; Julie Stephens, The Ohio State Univeristy; Vedat Yildiz, The Ohio State University; Marilly Palettas, The Ohio State University; Songzhu Zhao, The Ohio State University; Xueliang Pan, The Ohio State Univeristy
|
Sample Size Re-Estimation and Other Midcourse Adjustments with Sequential Parallel Comparison Design
Rachel Silverman, University of North Carolina; Anastasia Ivanova, UNC at Chapel Hill
|
Design of Drug Combination Early Phase Cancer Trials Using Time to Toxicity Data
Marcio Diniz, Cedars Sinai Medical Center; José Jimenez, Politecnico di Torino; Andre Rogatko, Cedars Sinai Medical Center; Mourad Tiguiouart, Cedars Sinai Medical Center
|
Essential Role of Statistics in Publishing Medical Research Papers
Daniel Byrne, Vanderbilt University; Henry J Domenico, Vanderbilt; Li Wang, Vanderbilt
|
Deep Learning Econometrics
Guanhao Feng; Nicholas Polson, University of Chicago; Jianeng Xu, University of Chicago
|
Estimation of Locally Stationary Spatial Processes with Application to the American Community Survey
Daniel Weinberg, U.S. Census Bureau; Tucker McElroy, U. S. Census Bureau; Soumendra N Lahiri, North Carolina State University
|
dECiDe: software developed by Cytel and AstraZeneca for early clinical study design
Patrick D. Mitchell, Early Clinical Development AstraZeneca; Dominic Magirr, AZ IMED Biotech Unit, ECD Biometrics; Elizabeth Pilling, AZ IMED Biotech Unit, ECD Biometrics; James Matcham, AZ IMED Biotech Unit, ECD Biometrics; Jaydeep Bhattacharyya, Cytel Inc.; Charles Liu, Cytel Inc.
|
Improving Power in Group Sequential, Randomized Trials by Adjusting for Prognostic Baseline Variables and Short-Term Outcomes
Tianchen Qian, Johns Hopkins University; Michael Rosenblum, Johns Hopkins University; Huitong Qiu, Vatic Lab
8:35 AM
|
Controlling Sources of Inaccuracy in Stochastic Kriging
Wenjia Wang, Georgia Institute of Technology
8:35 AM
|
Statistical Methods for Prediction of High-Performance Computing I/O Variability
Li Xu, Virginia Tech
8:50 AM
|
A Simulation Based Clinical Trial Design for Time-To-Event Endpoint Using the Concept of Relative Time Utilizing the Generalized Integer Gamma Distribution
Milind Phadnis
8:50 AM
|
Experiment Design and Analysis for Novel Computer Hardware Testing
Sarah Michalak, Los Alamos National Laboratory; Lisa Moore, Los Alamos National Laboratory; John Daly, University of Maryland; Nathan DeBardeleben, Los Alamos National Laboratory; Gary Delp, Mayo Clinic; Laura Monroe, Los Alamos National Laboratory; Heather Quinn, Los Alamos National Laboratory; James Rose, Mayo Clinic
9:05 AM
|
Assessing the Impact of Adopting a Mixed-Mode Design: Examining Respondent Skip Logic Errors in the 2015 Residential Energy Consumption Survey
Kevin Adams, RTI International; Peter Frechtel, RTI International; Amang Sukasih, RTI International
9:20 AM
|
Dual-Purpose Bayesian Design for Parameter Estimation and Model Discrimination of Models with Intractable Likelihoods
Mahasen Bandara Dehideniya, Queensland University of Technology; James McGree, Queensland University of Technology; Christopher Drovandi , Queensland University of Technology
9:20 AM
|
Optimal Design of Experiments with the Observation Censoring Driven by Random Enrollment of Subjects
Xiaoqiang Xue; Valerii Fedorov, ICONplc
9:50 AM
|
Mixed Methods for Analyzing Factors Important to Patients in Choosing a Dialysis Modality
Jarcy Zee, Arbor Research Collaborative for Health; Lalita Subramanian, Arbor Research Collaborative for Health; Junhui Zhao, Arbor Research Collaborative for Health; Francesca Tentori, Arbor Research Collaborative for Health; Vanderbilt University
9:55 AM
|
Enrichment by Response: Sequential Parallel Comparison Design
Anastasia Ivanova, UNC at Chapel Hill
10:35 AM
|
A Site-Adjusted Approach to the Covariate-Adjusted Response-Adaptive Allocation Design in Multi-Center Trials
Brian Di Pace, Virginia Commonwealth Univ; Roy T Sabo, Virginia Commonwealth University
10:50 AM
|
Estimators and Confidence Intervals for Adaptive Two-Stage Designs for Population Enrichment
Vladimir Dragalin, Janssen R&D; Ionut Bebu, The George Washington University
10:55 AM
|
Challenges in Measuring Health Insurance Coverage
Jennifer Cheeseman Day, US Census Bureau; Marina Vornovitsky, US Census Bureau
11:00 AM
|
An Adaptive Subgroup-Identification Enrichment Design
Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Florica Constantine, Johns Hopkins University
11:15 AM
|
An Embedded Experiment for Targeted Nonresponse Follow-Up in Establishment Surveys
Stephen Kaputa, U.S. Census Bureau; Katherine Thompson, U.S. Census Bureau; Jennifer Beck, National Science Foundation
11:50 AM
|
Deep Learning Econometrics
Guanhao Feng; Nicholas Polson, University of Chicago; Jianeng Xu, University of Chicago
11:50 AM
|
Adaptive Design by Benchmarked Sequential Sampling and Benchmarked Multiple Imputation
Shin-Jung Lee, University of Michigan
12:05 PM
|
The Role of Intermediate Observations When Outcome Data Are Missing in Longitudinal Randomized Clinical Trials
Joseph Rausch, Nationwide Children's Hospital
2:05 PM
|
A Simple and Flexible Graphical Approach for Adaptive Group-Sequential Clinical Trials
Frank Bretz, Novartis AG; Toshifumi Sugitani, Astellas; Willi Maurer, Novartis
2:05 PM
|
Predictive Evidence Threshold Scaling: Does the Evidence Meet a Confirmatory Standard?
Satrajit Roychoudhury, Pfizer Inc; Beat Neuenschwander, Novartis Pharma AG; Michael Branson, Novartis Pharma AG
2:20 PM
|
Adaptive Multi-Arm Multi-Stage Designs
Cyrus Mehta, Cytel Inc; Pranab Ghosh, Cytel Inc, Boston University
2:25 PM
|
Consulting Dish Cooked Three Different Ways: The Recipe and Execution of the Dish from the Side of Academics
Nairanjana Dasgupta, Washington State University
2:35 PM
|
Optimum Designs for Nonlinear Models in the Presence of Multiple Covariates
Mahbub AHM Latif, St. Luke's International University; Barbara Bogacka, Queen Mary, University of London; Steven G Gilmour, King's College London
2:35 PM
|
Accuracy in Parameter Estimation for a General Class of Effect Sizes: a Sequential Approach
Ken Kelley, University of Notre Dame; Francis B. Darku, University of Texas - Dallas; Bhargab Chattopadhyay, Indian Institute of Information Technology - Vadodara
2:35 PM
|
Designing Multi-Stage Clinical Trials with Multiple Event-Time Endpoints
Toshimitsu Hamasaki, National Cerebral and Cardiovascular Center; Scott Evans, Harvard University ; Tomoyuki Sugimoto, Kagoshima University; Koko Asakura, National Cerebral and Cardiovascular Center
2:45 PM
|
ASID: A Bayesian Adaptive Subgroup-Identification Enrichment Design
Florica Constantine, Johns Hopkins University; Yanxun Xu, Johns Hopkins University; Yili L Pritchett, MedImmune; Zhilin Jin, Johns Hopkins University
2:50 PM
|
Users Are Part of the System: How to Account for Human Factors When Designing Operational Tests for Software Systems
Kelly McGinnity, Institute for Defense Analyses; Heather Wojton, Institute for Defense Analyses
2:50 PM
|
Design Weight and Calibration
Kelly Toppin, National Agricultural Statistics Service; Luca Sartore, National Institute of Statistical Sciences; Clifford Spiegelman, Texas A&M University
2:50 PM
|
Design of Experiments for Networks with Interference
Alexander Volfovsky, Duke University
2:55 PM
|
Did We Commit a Type III Error?: Understanding the Hypothesis Test in Relation to the Experimental Objective
Rebecca Dickinson, IDA; Tom Johnson, IDA
3:05 PM
|
Confirmatory Group Sequential Adaptive Designs for Time-To-Event Endpoints Using a Short-Term Endpoint for Treatment Arm or Population Selection
Gernot Wassmer, Medical University of Vienna, Austria; Martin Posch, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University o; Franz Koenig, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University o; Silke Joergens, ICON Clinical Research Inc, Cologne Germany
3:05 PM
|
Estimation of Capture Probabilities by Accounting for Sample Designs
Jonathon Abernethy; Luca Sartore, National Institute of Statistical Sciences; Habtamu Benecha, USDA National Agricultural Statistics Service; Clifford Spiegelman, Texas A&M University
3:05 PM
|
Redesigning Introduction to Biostatistics
Kari Lock Morgan, Penn State University
3:20 PM
|
Clinical Trial Designs of Predictive Markers
Meijuan Li, CDRH/FDA
3:25 PM
|
|
Tuesday, 08/01/2017
|
Comparison of Model-Based to Design-Based Ratio Estimators
James Knaub, Retired
|
A Bayesian Approach to Factor Screening in Life Tests
I-Tang Yu
|
Precision Medicine Opportunities in Mental Health
Michael R Kosorok, University of North Carolina at Chapel Hill
|
Sample Design and Weighting for Estimating a Dose-Response Curve
Sharon Lohr, Westat; Pamela Broene, Westat; Eric Jodts, Westat
|
Effects of Link Misspecification in Propensity Score Weighting Adjustment
Samantha Spiers, LSUHSC School of Public Health, Biostatistics Program; Evrim Oral, LSUHSC School of Public Health
|
Simulation of Realistic Genome-Wide Autosomal Genotype Data
David Umbach, National Institute of Environmental Health Sciences; Min Shi, National Institute of Environmental Health Sciences; Alison Wise, unaffiliated; Clare Weinberg, National Institute of Environmental Health Sciences
|
Design Specifications of Performance for an Analytical Laboratory Method
Beimar Iriarte, Abbott Laboratories
|
Rank Regression in Order Restricted Randomized Designs
Jinguo Gao, Google Inc.; Omer Ozturk, Ohio State University
|
Sequential Computer Experiments for Failure Probability Estimation --- a Floor System Example
Hao Chen, University of British Columbia; William James Welch, University of British Columbia
|
A Bayesian Sequential Design with Adaptive Randomization for Two-Sided Hypothesis Tests
Qingzhao Yu, Louisiana State University Health Sciences Center; Lin Zhu, Louisiana State University Health Sciences Center; Han Zhu, Pharmaceutical Product Development, Inc.
|
Optimal Designs for Pharmacokinetic Studies Analyzed Using Non-Compartmental Methods
Helen Barnett, Lancaster University; Thomas Jaki, Lancaster University; Helena Geys, Janssen Pharmaceutica; Tom Jacobs, Janssen Pharmaceutica
|
Statistical Considerations in Delayed-Start Design to Demonstrate Disease Modification Effect in Neurodegenerative Disorders
Jun Zhao, AbbVie Inc.; Deli Wang, AbbVie, Inc.; Weining Z Robieson, AbbVie Inc.
|
Design and Statistical Analysis of Method Transfer Studies for Biotechnology Products
Meiyu Shen, C DER, FDA; Lixin Xu, FDA
|
Optimal Tradeoffs in Matched Designs for Observational Studies
Samuel Pimentel, Wharton; Rachel R. Kelz, University of Pennsylvania
|
Marginalization Over Uncertainty in Propensity Score Design Using Bayesian Analysis
Shirley Liao; Corwin Zigler, Harvard University
|
Contextualizing Sensitivity Analysis in Observational Studies: Calculating Bias Factors for Known Covariates
Lucy D'Agostino McGowan; Robert A Greevy, Jr, Vanderbilt University
|
Accounting for Baseline Covariates and Missing Data in Regulatory Trials with Longitudinal Designs
Elizabeth Colantuoni, Johns Hopkins University; Jon Steingrimsson, Johns Hopkins University; Aidan McDermott, Johns Hopkins University; Michael Rosenblum, Johns Hopkins University
|
Tests and Classifications in Adaptive Designs with Applications
Qiusheng Chen, Florida State University; Xufeng Niu, Florida State University
8:35 AM
|
Changes to the Sample Design and Frame of a National Survey of People Living with HIV
Christopher Johnson, CDC; Ronaldo Iachan, ICF International; Richard Lee Harding, ICF; Adam Lee, ICF; Tonja Kyle, ICF; Jason Craw, CDC; Linda Beer, CDC; Roy L. Shouse, CDC
8:35 AM
|
Accounting for Baseline Covariates and Missing Data in Regulatory Trials with Longitudinal Designs
Elizabeth Colantuoni, Johns Hopkins University; Jon Steingrimsson, Johns Hopkins University; Aidan McDermott, Johns Hopkins University; Michael Rosenblum, Johns Hopkins University
8:45 AM
|
A Two-Stage Design for Phase III Trials with Population Selection
Wen Li, Merck & Co. Inc.
8:50 AM
|
Bayesian Clinical Trial Design for Joint Models of Longitudinal and Survival Data
Joseph G Ibrahim, UNC; Matthew Psioda, UNC Chapel Hill
9:00 AM
|
When Should We Use Linear Fixed Effects Regression Models for Causal Inference with Longitudinal Data?
Kosuke Imai, Princeton University; In Song Kim, MIT
9:00 AM
|
A Practical Bayesian Adaptive Design with Application to Cardiovascular Outcomes Trials
Matthew Psioda, UNC Chapel Hill; Joseph G Ibrahim, UNC; Mat Soukup, Center for Drug Evaluation and Research, Office of Translational Sciences, FDA
9:05 AM
|
Optimal Tradeoffs in Matched Designs for Observational Studies
Samuel Pimentel, Wharton; Rachel R. Kelz, University of Pennsylvania
9:15 AM
|
Earning Regulatory Approval for a Phase II/III Design: a Case Study from Start to Finish
Adam Hamm, Cytel, Inc.
9:20 AM
|
Sequential Computer Experiments for Failure Probability Estimation --- a Floor System Example
Hao Chen, University of British Columbia; William James Welch, University of British Columbia
9:20 AM
|
Analyzing Definitive Screening Designs Taking Advantage of Their Structure
Bradley Allen Jones, JMP Division/SAS
9:25 AM
|
Optimal Designs for Pharmacokinetic Studies Analyzed Using Non-Compartmental Methods
Helen Barnett, Lancaster University; Thomas Jaki, Lancaster University; Helena Geys, Janssen Pharmaceutica; Tom Jacobs, Janssen Pharmaceutica
9:35 AM
|
Adaptive Designs in Phase II Basket Clinical Trials
Kristen Cunanan; Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center; Ronglai Shen, Memorial Sloan Kettering Cancer Center; Colin Begg, Memorial Sloan Kettering Cancer Center; Mithat Gonen, Memorial Sloan Kettering Cancer Center
9:35 AM
|
Deriving a Person-Level Weight for Analyzing MEPS Supplemental Data from a Linked Medical Organization Survey
Marc Zodet, Agency for Healthcare Research and Quality; Sadeq R Chowdhury, Agency for Healthcare Research and Quality; Steven Machlin , Agency for Healthcare Research and Quality
9:35 AM
|
Statistical Considerations in Delayed-Start Design to Demonstrate Disease Modification Effect in Neurodegenerative Disorders
Jun Zhao, AbbVie Inc.; Deli Wang, AbbVie, Inc.; Weining Z Robieson, AbbVie Inc.
9:40 AM
|
Contextualizing Sensitivity Analysis in Observational Studies: Calculating Bias Factors for Known Covariates
Lucy D'Agostino McGowan; Robert A Greevy, Jr, Vanderbilt University
9:50 AM
|
Design and Statistical Analysis of Method Transfer Studies for Biotechnology Products
Meiyu Shen, C DER, FDA; Lixin Xu, FDA
10:05 AM
|
New Adaptive Designs of Clinical Trial for Precision Medicine
Feifang Hu, George Washington University
10:35 AM
|
Empirical Assessment of Programs to Promote Collaboration: a Network Model Approach
Katherine McLaughlin, Oregon State University; Joshua D. Embree, RAND Corporation
10:35 AM
|
A Bayesian Sequential Design with Adaptive Randomization for Two-Sided Hypothesis Tests
Qingzhao Yu, Louisiana State University Health Sciences Center; Lin Zhu, Louisiana State University Health Sciences Center; Han Zhu, Pharmaceutical Product Development, Inc.
11:10 AM
|
Propensity-Score-Based Priors for Bayesian Augmented Control Design
Junjing Lin, AbbVie ; Margaret Gamalo-Siebers, Eli Lilly; Ram Tiwari, FDA/CDER/OT/OB
11:15 AM
|
A Bayesian Mixed-Effects Model for Microbiome Data from Designed Experiments
Neal Grantham, North Carolina State University; Brian Reich, NCSU; Kevin Gross, North Carolina State University
11:15 AM
|
A Review of the Sample Size Calculations of Randomised Controlled Trials Funded by One of the Leading Funders in the UK
Steven Julious, University of Sheffield; Jo Rothwell, University of Sheffield
11:15 AM
|
Statistical Considerations for an Adaptive Design for a Serious Rare Disease
Gary R Cutter, UAB School of Public Heatlh Department of Biostatistics
11:25 AM
|
Analysis of Clustered Complex Design Data: Propensity Score Matching
Mi-Ok Kim, UCSF
11:25 AM
|
A Comparison of Propensity Score Design and Test Negative Case-Control Study Outcomes for Rotavirus Vaccine Effectiveness
Elizabeth Zell; Michelle Groome, RMPRU
11:35 AM
|
Strategies in Designing Interim Analyzes Under Discrete Random-Effects Model in a Multiregional Trial
Hsiao-Hui Tsou, National Health Research Institutes; Chi-Tian Chen, National Health Research Institutes; K. K. Gordon Lan, Janssen Pharmaceutical Companies of Johnson & Johnson; Chin-Fu Hsiao, National Health Research Institutes
11:35 AM
|
Regression Power Analysis for a Linear Regression Model When Regressors Are Matrix-Sampled
Stanislav Kolenikov, Abt Associates; Heather Hammer, Abt Associates
11:50 AM
|
Multi-Arm Multi-Stage Group Sequential Design in Clinical Trial
Pranab Ghosh, Cytel Inc, Boston University; Cyrus Mehta, Cytel Inc
11:50 AM
|
Marginalization Over Uncertainty in Propensity Score Design Using Bayesian Analysis
Shirley Liao; Corwin Zigler, Harvard University
11:50 AM
|
Extension of the Two-Stage Randomized Trial Design for Testing Treatment, Self-Selection, and Treatment Preference Effects to Binary Outcomes
Briana Cameron, Yale University; Denise Esserman, Yale School of Public Health; Peter Peduzzi, Yale School of Public Health
12:05 PM
|
Scrum for Students: Increasing Productivity and Mastery in Statistics with an Agile Process
Ellen Endriss, Career Center
12:05 PM
|
Estimating Continuous Long-Term Daily Health Behavior Using Missing by Design Methods with Application for Medication Adherence of People Living with HIV
Ofer Harel, University of Connecticut
2:05 PM
|
The Cost of Comparing Survival Curves Using Multiple Measures
Godwin Yung, Takeda Pharmaceutical; Yi Liu, Takeda; Mingxiu Hu, Takeda Pharmaceutical
2:05 PM
|
Spatial Small Area Smoothing Models for Handling Survey Data with Nonresponse
Kevin Watjou, Hasselt University; Christel Faes, University Hasselt; Russell S. Kirby, College of Public Health, University of South Florida; Andrew Lawson, Department of Public Health Sciences, Medical University of South Carolina; Rachel Carroll, National Institute of Environmental Health Sciences; Mehreteab Aregay, Department of Public Health Sciences, Medical University of South Carolina; Yannick Vandendijck, University Hasselt
2:05 PM
|
An Evaluation of Increasing Sample Size Based on Conditional Power
Michael Gaffney, Pfizer Inc.
2:05 PM
|
Design of Order-Of-Addition Experiments Under the Pairwise-Order Framework
Jiayu Peng, Penn State University; Dennis K.J. Lin, Penn State University
2:05 PM
|
Local Variable Selection in Sequential Optimization
Munir Winkel, North Carolina State University; Brian Reich, NCSU; Jonathan W. Stallings, North Carolina State University
2:05 PM
|
Multiple Testing Procedures in Group Sequential Designs: Comparing Methods and New Proposals
Man Jin, Merck Research
2:20 PM
|
Designing for What's Important: a Comparison of Bayesian and General Weighted Optimality Criteria
Jonathan W. Stallings, North Carolina State University
2:20 PM
|
Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-Assessment
Sam Hsiao, Cytel, Inc; Lingyun Liu, Cytel, Inc; Cyrus Mehta, Cytel Inc
2:25 PM
|
Multiplicity Adjustment Approaches in Multiple Endpoint Study with Group Sequential Designs
Sunhee Ro; Muhtar Osman, Amgen
2:35 PM
|
Eliciting Priors and Tradeoffs to Assist in the Design of Clinical Studies
Joseph Kahn, Novartis Pharmaceuticals
2:45 PM
|
Design Based Estimates of Model Based Parameters
Eric Morenz, McGill University; Russell Steele, McGill University; Ana Velly, Jewish General Hospital, McGill University
2:50 PM
|
Strategies for Mixture-Design Space Augmentation
Martin Bezener, Stat-Ease, Inc.
2:50 PM
|
Locally D-Optimal Designs for Logistic Regression Models with Factorial Effects
Zhongshen Wang, Arizona State University; John Stufken, Arizona State University
3:05 PM
|
Adapting the 5-Zone Adaptive Design
Yi Liu, Takeda; Mingxiu Hu, Takeda Pharmaceutical
3:05 PM
|
Robust Dose-Level Designs for Binary Responses
Wanchunzi Yu; John Stufken, Arizona State University
3:20 PM
|
Implementation of Promising Zone Methodology in a Ph 3 Trial in AML (VALOR)
Jennifer Smith, Sunesis
3:25 PM
|
|
Wednesday, 08/02/2017
|
Statistical Design and Analysis in DoD Test and Evaluation
Laura Freeman, IDA
|
A Bayesian Structural Model for Designing Financial Incentive Offers to Automotive Dealerships
Wenyi Wu, University of Michigan; Peter Lenk, University of Michigan
|
Statistical Considerations for Rare Disease Clinical Development
Yang Song, Vertex Pharmaceuticals
|
Beyond the Statistical Analysis Plan: Statisticians Partaking Earlier in Design of Clinical Trials
Yuqun Abigail Luo, FDA
|
Optimal step-stress accelerated life test under Type-I censoring with flexible stress durations
Tianyu Bai, University of Texas at San Antonio; David Han, University of Texas At San Antonio
|
Real World Evidence to Support Accelerated Approval Processes
Sebastian Schneeweiss, Harvard Medical School; Jessica Franklin, Harvard Medical School
8:35 AM
|
BOP2: Bayesian Optimal Designs for Phase II Clinical Trials with Simple and Complex Endpoints
Heng Zhou, MD Anderson Cancer Center; Ying Yuan, M.D. Anderson Cancer Center
8:35 AM
|
Bayesian A-Optimal Design of Experiment with Quantitative and Qualitative Responses
Lulu Kang, Illinois Institute of Technology-Department of Applied Mathematics
8:35 AM
|
Randomization Inference for Peer Effects
Xinran Li, Harvard University; Peng Ding, University of California, Berkeley; Qian Lin, Harvard University; Dawei Yang, Peking University; Jun Liu, Harvard University
8:35 AM
|
Designing Computer Experiments to Maximize Prediction Accuracy
Erin Leatherman, West Virginia University; Angela Dean, The Ohio State University; Thomas Santner, The Ohio State University
8:55 AM
|
Designing a Robust Monitoring Scheme for Natural Resources at a Continental Scale
Emily L Weiser, U.S. Geological Survey; James E. Diffendorfer, U.S. Geological Survey; Laura López-Hoffman, The University of Arizona; Darius J Semmens, U.S. Geological Survey; Wayne E Thogmartin, U.S. Geological Survey
8:55 AM
|
Subgroup Identification of Early Preterm Birth (EPTB): Informing a Future Prospective Enrichment Clinical Trial Design
Chuanwu Zhang, University of Kansas Medical Center
9:05 AM
|
A Discrete-Time Microsimulation Model of the 2016 Canadian Census Collection Operations: An Innovative Method for Responsive Design and Cost Control
Vincent Martin, Statistics Canada
9:05 AM
|
Sequential Optimal Experimental Design Using Adaptive Transport Maps
Xun Huan, Sandia National Laboratories; Youssef Marzouk, Massachusetts Institute of Technology
9:15 AM
|
Optimal Dynamic Sampling of a Spreading Population
Perry Williams, Colorado State University; Mevin Hooten, Colorado State University; Jamie N Womble, National Park Service; George G Esslinger, U.S. Geological Survey Alaska Science Center; Michael R Bower, National Park Service
9:15 AM
|
Bayesian Design for Interim Analysis
Dung-Tsa Chen, Moffitt Cancer Center
9:20 AM
|
Estimation in Multisite Randomized Trials with Heterogeneous Treatment Effects
Daniel Schwartz, University of Chicago; Stephen Raudenbush, University of Chicago
9:20 AM
|
Statistical Design Considerations for Utilizing Real World Data in Premarket Evaluation of Medical Devices
Yunling Xu, CDRH/FDA; Nelson Lu, CDRH/FDA; Lilly Yue, Division of Biostatistics, CDRH/ U.S. FDA; Ram Tiwari, FDA/CDRH
9:25 AM
|
Stochastic Optimization of Adaptive Enrichment Designs for Two Subpopulations
Michael Rosenblum, Johns Hopkins University; Aaron Fisher, Harvard University-Department of Biostatistics; Joshua A Betz, Johns Hopkins University; Jon Steingrimsson, Johns Hopkins University
9:35 AM
|
The MEPS Medical Organizations Survey: Lessons Learned on Non-Response and Data Quality from a Linked Survey Data Collection Strategy
Monica Wolford, Agency for Healthcare Research & Quality; Adam Biener, Agency for Healthcare Research and Quality ; Marie Stagnitti, Agency for Healthcare Research and Quality
9:35 AM
|
Score Test for Case-Cohort Design Applied to High-Throughput Gene Expression Analysis
Huining Kang, University of New Mexico; John Carl Pesko, University of New Mexico
9:35 AM
|
Introductory Statistics Students' Conceptual Understanding of Study Design and Conclusions
Elizabeth Fry, University of Minnesota
9:35 AM
|
Interviewer Effects on Racially-Sensitive Questions and Biomeasures: Results from a Semi-Interpenetrated Design
Matt Jans, Abt Associates; Trivellore Raghunathan, University of Michigan School of Public Health; Mick P. Couper, Michigan Program in Survey Methodology
9:50 AM
|
Inferences from Various Study Designs for Companion Diagnostic Device Evaluation
Jeng Mah, Beckman Coulter
9:50 AM
|
Practical Considerations for Designing Pediatric Trials
Jerry Weaver, Celgene
9:50 AM
|
Estimand in Evaluating Predictive or Selection Markers Using Enrichment Design in Clinical Trials
Jingjing Ye, FDA
9:55 AM
|
Replication or exploration? Sequential design for stochastic simulation experiments.
Robert Gramacy, Virginia Tech Department of Statistics; Bickael Binois, The University of Chicago; Mike Ludkovski, University of California, Santa Barbara
10:35 AM
|
Empirical Likelihood Inference for Complex Surveys and the Design-Based Oracle Variable Selection Theory
Changbao Wu, University of Waterloo; Puying Zhao, University of Waterloo; David Haziza, University of Montreal
10:35 AM
|
On the Development of a Parametric Approach for the Estimation of Totals and Means for Complex Survey Sample Data in the Presence of Full Response
Ismael Flores Cervantes, Westat
10:50 AM
|
On the Estimation of Time-Varying Effects in the Nested Case-Control Design
Michelle Nuno; Daniel L. Gillen, University of California, Irvine
10:55 AM
|
Simultaneous Confidence Intervals from Stochastic Approximation
Rongji Mu, East China Normal University; Cui Xiong, East China Normal University; Jin Xu, East China Normal University
10:55 AM
|
Bayesian Estimation of Case-Crossover Designs with Repeated Events
Daniel L. Gillen, University of California, Irvine; Sevan Gulesserian, University of California, Irvine
11:15 AM
|
Statistical Inference of the Relative Concentration Index Using Grouped Data from Complex Surveys
Mandi Yu, National Cancer Institute; Meng Qiu, University of Maryland; Yan Li, University of Maryland
11:15 AM
|
Edit Reduction: Identifying Possible Stopping Points and Moving Toward Adaptive Design Techniques
Lisa Kaili Diamond, US Census Bureau; Justin Nguyen, U.S. Census Bureau; Brian Arthur Dumbacher, U.S. Census Bureau
11:20 AM
|
Optimal Designs for Binary Response Models with Multiple Nonnegative Variables
Mong-Na Lo Huang, National Sun Yat-Sen Univ; Shih-Hao Huang, National Sun Yat-sen University; Cheng-Wei Lin, National Sun Yat-sen University
11:20 AM
|
Stabilizing Gradient Enhanced Emulators with Sparsity Constraints
Peter Qian, University of Wisconsin-Madison ; Jared Huling, University of Wisconsin-Madison
11:25 AM
|
Multiple Contrast Tests and Simultaneous Confidence Intervals in High-Dimensional Repeated Measures Designs
Frank Konietschke, University of Texas at Dallas
11:35 AM
|
Innovative Applications for Linking Health Survey Data to Vital and Administrative Data
Lisa B Mirel, CDC/NCHS/OAE/SPB; Cordell Golden, National Center for Health Statistics (NCHS)
11:35 AM
|
Model-based Design for the Early Development of Cancer Immunotherapy Combinations
Nolan Wages, University of Virgina
11:35 AM
|
Biomarker Based Study Design with Multiple Single Arms
Shiling Ruan, Novartis
11:35 AM
|
An Optimal Covariate-Adaptive Design to Balance Tiers of Covariates
Fan Wang; Feifang Hu, George Washington University
11:50 AM
|
Experimental Design in Longitudinal MRI for Multiple Sclerosis
Menghan Hu, Brown University; Ani Eloyan, Brown University; Matthew Schindler, NIH, NINDS; Daniel Reich, NINDS; Russell Taki Shionhara, UPenn; Blake Dewey, Johns Hopkins Whiting School of Engineering
11:50 AM
|
RCAP Designer: Creating Analytical Dashboards on the RCloud Platform
Robert Archibald, Macrosoft Inc; Ganesh Subramaniam, AT&T; Simon Urbanek, AT&T Labs Research
11:50 AM
|
Design and Analysis of Single Arm Clinical Trials Involving Highly Heterogeneous Subjects
Sherry Liu, FDA
11:55 AM
|
Current Practices in Reporting Trial Simulations for Adaptive Study Designs
cristiana mayer, Janssen R&D; Parvin Fardipour, ICON
2:05 PM
|
A Review of Weighting Assumptions for Geosampling-Based Survey Designs: a Case Study in Nigeria
Jennifer Unangst, RTI International; Safaa Amer, RTI International
2:05 PM
|
Proposed Guidelines for Interim Monitoring of Prospective Observational Studies Planning to Invoke Propensity-Scoring as the Primary Analysis
Michael Swartz, The University of Texas Health Science Center At Houston, School of Public Health; Thomas Jay Greene, The University of Texas Health Science Center at Houston, School of Public Health; Erin E Fox, The University of Texas Health Science Center, Center for Translational Injury Research; Savitri N. Appana, The University of Texas Health Science Center at Houston; Misung Yi, The University of Texas Health Science Center at Houston, School of Public Health; Soeun Kim, The University of Texas Health Science Center at Houston, School of Public Health; Elysia A. Garcia, The University of Texas Health Science Center at Houston, School of Public Health; Jada M. Johnson, The University of Texas Health Science Center at Houston, School of Public Health; Jeanette Podbielski, The University of Texas Health Science Center, Center for Translational Injury Research; Jeffrey S. Tomasek, The University of Texas Health Science Center, Center for Translational Injury Research; Charles E. Wade, The University of Texas Health Science Center, Center for Translational Injury Research; John B. Holcomb, The University of Texas Health Science Center at Houston; Stacia M DeSantis, UTHealth SPH
2:05 PM
|
On Sensitivity Value of Pair-Matched Observational Studies
Qingyuan Zhao, University of Pennsylvania
2:20 PM
|
Recent Advances in Quality Statistics and Process Validation of Pharmaceuticals
Lynne Hare, Statistical Strategies, LLC
2:25 PM
|
Practical Considerations on Simulations for Adaptive Dose Escalation and Dose Ranging Trials
Inna Perevozskaya, Glaxo SmithKline; Alun Bedding, Roche UK; Vladimir Dragalin, Janssen R&D; Parvin Fardipour, ICON
2:25 PM
|
Predicting Solar Irradiance as a Function of Location and Time: Multiple Model Calibration, Non-Stationarity, and Non-Space-Filling Design
Benjamin Haaland, Georgia Institute of Technology
2:25 PM
|
Optimal Design for Classification of Functional Data
Cai Li, North Carolina State University; Luo Xiao, North Carolina State University
2:35 PM
|
Simulation Considerations for Multistage Adaptive Designs and Designs with Sample Size Re-Estimation: Type 1 Error Control and Beyond
Greg Cicconetti, Abbvie; Sergei Leonov, ICON Clinical Research; Yili L Pritchett, MedImmune; Michael Smith, Astellas; Alan Hartford, AbbVie
2:45 PM
|
Non-Inferiority Trial Design by Considering Maximally/Minimally Observed Treatment Difference
Shufang Liu, Astellas Pharma; Misun Lee, Astellas Pharma
2:50 PM
|
Evaluation of Simulation Models Through Different Computational Environments
Jiang Hu, FDA
3:05 PM
|
Semiparametric Varying-Coefficient Nonlinear Regression for Interactions in Multifactor ANOVA Models with Unbalanced or Single Replications
Yumin Huang, Tunghai University
3:20 PM
|
Survey Designs with Small Stratum Sample Sizes
Xiaofei Zhang, Iowa State University; Emily Berg, Iowa State University; Wayne A. Fuller, Iowa State University
3:20 PM
|
How Suited Is Propensity Score Matching for Combining Data from Different Sources?
Florian Meinfelder, Universitaet Bamberg
3:25 PM
|
Immunogenicity Study Design for Biosimilar Approval
Junshan Qiu, FDA; Mike Mikailov, FDA; Ram Tiwari, FDA/CDER/OT/OB
3:35 PM
|
|
Thursday, 08/03/2017
|
Incorporating Pharmacokinetic Assessment in Bayesian Phase I Trial Design in Oncology Area
Kentaro Takeda, Astellas Pharma Global Development, Inc.; Kanji Komatsu, Astellas Pharma Inc.; Satoshi Morita, Kyoto University Graduate School of Medicine
8:50 AM
|
Bayesian Design Applications for Medical Devices Trials Using Power Prior
Songtao Jiang, Boston Scientific Corporation; Peter Lam, Boston Scientific Corporation; Hong Wang, Boston Scientific Corporation
8:50 AM
|
Variable Selection for Case-Cohort Studies with Failure Time Outcome
Jianwen Cai, University of North Carolina at Chapel Hill; Ai Ni, Memorial Sloan Kettering Cancer Center; Donglin Zeng, University of North Carolina
8:55 AM
|
Using Ranked Set Sampling with Binary Outcomes in Cluster Randomized Designs
Mumu Wang, Southern Methodist University; Xinlei Wang, Southern Methodist University; Johan Lim, Seoul National University
9:15 AM
|
Design of Phase I/II Drug Combination Cancer Trials Using CRM and Adaptive Randomization
Mourad Tighiouart, Cedars-Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center
9:20 AM
|
Bayesian analysis of sparse counts under the unrelated question design
Balgobin Nandram, Worcester Polytechnic Institute
9:35 AM
|
A Personalized Bayesian Information-Driven Dose-Finding Design
Ilaria Domenicano, Dana-Farber Cancer Institute/University of Rome
9:35 AM
|
COMPLEX SURVEY DESIGNS for SIMULTANEOUS ESTIMATION of TOTALS of TWO SENSITIVE VARIABLES
Segun Ahmed, Texas A & M University-Kingsville; Sarjinder Singh, Texas A&M University-Kingsville; Stephen A. Sedory, Texas A&M University-Kingsville
9:35 AM
|
Optimizing Acute Myelogenous Leukemia Treatment Regimes via Sequential Conditional Structural Mean Models
Geoffrey Johnson, GlaxoSmithKline; Abdus Wahed, University of Pittsburgh
9:50 AM
|
Continual Reassessment Method for Partially Ordered Groups
Bethany Horton, The University of Virginia; Nolan Wages, The University of Virginia; Mark Conaway, The University of Virginia
10:05 AM
|
Bayesian Model Averaging in Multiple Imputation Under Informative Sampling
Gyuhyeong Goh, Kansas State University; Jae-kwang Kim, Iowa State University
10:35 AM
|
Motivation and Design of the DIA Adaptive Design Scientific Working Group (DIA ADSWG) Survey for the Perception and Use of Adaptive Designs in Pharmaceutical Clinical Development
Alan Hartford, AbbVie
10:35 AM
|
A Robust Paradigm of Finding the Maximum Tolerated Dose in Phase I Cancer Clinical Trials
Tina Young, Bristol-Myers Squibb; Dirk Moore, Rutgers School of Public Health; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health
10:50 AM
|
Evaluating Imaging Inclusion Criteria for Stroke Clinical Trials: Appropriate Enrichment Versus Cherry Picking
Robyn L Ball, Stanford University; Bin Jiang, Stanford University; Manisha Desai, Stanford University; Max Wintermark, Stanford University
10:50 AM
|
Dr. Ernest Seglie's Career at DoD
Nancy Spruill, US Office of the Secretary of Defense
10:55 AM
|
Impact of Assessment of Schedule Interval Change on Median Progression-Free Survival Estimate
Shuyan Wan, Merck
11:05 AM
|
Literature Review Providing a Summary of Adaptive Design Usage in Pharmaceutical Clinical Development
Xiaotian Chen
11:15 AM
|
SHRP2 Naturalistic Engagement of Secondary Tasks (NEST) Distracted Driving Dataset: Baseline Sampling Method and Implications for Crash Risk Approximations
Birsen Donmez, University of Toronto
11:15 AM
|
Ernest Seglie's Statistical Contributions to DOD TandE
Arthur Fries, IDA
11:15 AM
|
The Design of the School Physical Activity and Nutrition (SPAN) 2015-2016 Study
Adriana Perez, Univ of Texas At Houston Health Sci Ctr; Nalini Ranjit, The University of Texas Health Science Center at Houston; Ramah Leith, Title V-Maternal and Child Health Office; Debra Saxton, Texas Department of State Health Services; James Custer, Michael & Susan Dell Center for Healthy Living; Deanna Hoelscher, The University of Texas Health Science Center at Houston
11:20 AM
|
A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy
Michelle DeVeaux, Yale University; Daniel Zelterman, Yale University; Michael Kane, Yale University
11:20 AM
|
Multi-Arm Bayesian Designs for Clinical Trials
Lorenzo Trippa, Dana-Farber Cancer Institute, Harvard
11:25 AM
|
Perception and Use of Adaptive Designs in Industry and Academia - Findings of a Review of Registries
Lingyun Liu, Cytel, Inc
11:35 AM
|
The Adaptive "learn-As-You-Go" Design for Multi-Stage Intervention Studies
Daniel Nevo, Harvard T.H. Chan School of Public Health; Judith Lok, Harvard T H Chan School of Public Health; Donna Spiegelman, Harvard T.H. Chan School of Public Health
11:35 AM
|
Statistical Design and Analysis for Plant Cover Studies with Multiple Sources of Observation Errors
Wilson Wright, US Geological Survey; Kathi Irvine, US Geological Survey; Jeffrey Warren, US Fish and Wildlife Service; Jenny Barnett, US Fish and Wildlife Service
11:50 AM
|
Two Overlooked Statistical Issues in the Study of Neurodevelopmental Trajectories
Philip Reiss, University of Haifa
11:55 AM
|
Comparison of the DIA Adaptive Design Scientific Working Group Surveys Conducted from 2000 Through 2015, with an emphasis on perceived and persistent barriers to adoption
Alun Bedding, Roche UK
11:55 AM
|
|
|
